FBR Capital Upgrades BioMed Realty (BMR) to Outperform; Move-out Risk Priced In
Tweet Send to a Friend
FBR Capital upgraded BioMed Realty (NYSE: BMR) from Market Perform to Outperform. PT $19.
FBR analyst says, "We believe that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "We believe that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
